🇺🇸 FDA
Pipeline program

filgrastim

CDR0000068379

Phase 3 mab active

Quick answer

filgrastim for Lung Cancer is a Phase 3 program (mab) at Solid Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Solid Biosciences
Indication
Lung Cancer
Phase
Phase 3
Modality
mab
Status
active

Clinical trials